Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
The 2014–15 Ebola outbreak in West Africa highlighted the potential for large disease outbreaks caused by emerging pathogens and has generated considerable focus on preparedness for future epidemics. Here we discuss drivers, strategies and practical considerations for developing vaccines against out...
Main Authors: | Katie Ewer, Sarah Sebastian, Alexandra J. Spencer, Sarah Gilbert, Adrian V. S. Hill, Teresa Lambe |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-12-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2017.1383575 |
Similar Items
-
Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
by: Ewer (nee Russell), K, et al.
Published: (2017) -
Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever
by: Meirong Wang, et al.
Published: (2021-03-01) -
Development of novel vaccine vectors: Chimpanzee adenoviral vectors
by: Jingao Guo, et al.
Published: (2018-07-01) -
A review of lassa fever outbreaks in Nigeria from 1969 to 2017: Epidemiologic profile, determinants and public health response
by: T J Okwor, et al.
Published: (2018-01-01) -
Recurring Outbreaks of Lassa Fever in Nigeria: Understanding the Root Causes and Strategies for the Future
by: Bashar Haruna Gulumbe, et al.
Published: (2023-06-01)